183 related articles for article (PubMed ID: 11156374)
21. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
22. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.
Heimann P; El Housni H; Ogur G; Weterman MA; Petty EM; Vassart G
Cancer Res; 2001 May; 61(10):4130-5. PubMed ID: 11358836
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
24. Genomic organization of human TCF12 gene and spliced mRNA variants producing isoforms of transcription factor HTF4.
Gan TI; Rowen L; Nesbitt R; Roe BA; Wu H; Hu P; Yao Z; Kim UJ; O'Sickey T; Bina M
Cytogenet Genome Res; 2002; 98(4):245-8. PubMed ID: 12826747
[TBL] [Abstract][Full Text] [Related]
25. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
26. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.
Knezevich SR; McFadden DE; Tao W; Lim JF; Sorensen PH
Nat Genet; 1998 Feb; 18(2):184-7. PubMed ID: 9462753
[TBL] [Abstract][Full Text] [Related]
27. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract][Full Text] [Related]
28. Localization of TEC to 9q22.3-q31 by fluorescence in situ hybridization.
Kleinfinger P; Labelle Y; Melot T; Thomas G; Delattre O; Aurias A
Ann Genet; 1996; 39(4):233-5. PubMed ID: 9037350
[TBL] [Abstract][Full Text] [Related]
29. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
Xia Y; Hwang LY; Cobb MH; Baer R
Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
[TBL] [Abstract][Full Text] [Related]
30. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
31. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
[TBL] [Abstract][Full Text] [Related]
33. Thermodynamics of the DNA binding reaction of transcription factor MASH-1.
K-unne AG; Sieber M; Meierhans D; Allemann RK
Biochemistry; 1998 Mar; 37(12):4217-23. PubMed ID: 9521744
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
35. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
[TBL] [Abstract][Full Text] [Related]
36. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
37. The PLAGL1 gene is down-regulated in human extraskeletal myxoid chondrosarcoma tumors.
Poulin H; Labelle Y
Cancer Lett; 2005 Sep; 227(2):185-91. PubMed ID: 16112421
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.
Brody RI; Ueda T; Hamelin A; Jhanwar SC; Bridge JA; Healey JH; Huvos AG; Gerald WL; Ladanyi M
Am J Pathol; 1997 Mar; 150(3):1049-58. PubMed ID: 9060841
[TBL] [Abstract][Full Text] [Related]
39. A TFG-TEC nuclear localization mutant forms complexes with the wild-type TFG-TEC oncoprotein and suppresses its activity.
Lim B; Kim AY; Jun HJ; Kim J
Biochem J; 2013 Dec; 456(3):361-72. PubMed ID: 24073693
[TBL] [Abstract][Full Text] [Related]
40. Regulation of oncogenic transcription factor hTAF(II)68-TEC activity by human glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Kim S; Lee J; Kim J
Biochem J; 2007 Jun; 404(2):197-206. PubMed ID: 17302560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
